252 related articles for article (PubMed ID: 31206358)
1. Association of Elevated Plasma Interleukin-18 Level With Increased Mortality in a Clinical Trial of Statin Treatment for Acute Respiratory Distress Syndrome.
Rogers AJ; Guan J; Trtchounian A; Hunninghake GM; Kaimal R; Desai M; Kozikowski LA; DeSouza L; Mogan S; Liu KD; Matthay MA; Steingrub J; Wheeler A; Yoon JH; Nakahira K; Choi AM; Baron RM
Crit Care Med; 2019 Aug; 47(8):1089-1096. PubMed ID: 31206358
[TBL] [Abstract][Full Text] [Related]
2. Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials.
Moore AR; Pienkos SM; Sinha P; Guan J; O'Kane CM; Levitt JE; Wilson JG; Shankar-Hari M; Matthay MA; Calfee CS; Baron RM; McAuley DF; Rogers AJ
Crit Care Med; 2023 Dec; 51(12):e269-e274. PubMed ID: 37695136
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17A Is Associated With Alveolar Inflammation and Poor Outcomes in Acute Respiratory Distress Syndrome.
Mikacenic C; Hansen EE; Radella F; Gharib SA; Stapleton RD; Wurfel MM
Crit Care Med; 2016 Mar; 44(3):496-502. PubMed ID: 26540401
[TBL] [Abstract][Full Text] [Related]
4. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients.
Jabaudon M; Futier E; Roszyk L; Chalus E; Guerin R; Petit A; Mrozek S; Perbet S; Cayot-Constantin S; Chartier C; Sapin V; Bazin JE; Constantin JM
Crit Care Med; 2011 Mar; 39(3):480-8. PubMed ID: 21220996
[TBL] [Abstract][Full Text] [Related]
5. Effect of total cholesterol and statin therapy on mortality in ARDS patients: a secondary analysis of the SAILS and HARP-2 trials.
Pienkos SM; Moore AR; Guan J; Levitt JE; Matthay MA; Baron RM; Conlon J; McAuley DF; O'Kane CM; Rogers AJ
Crit Care; 2023 Mar; 27(1):126. PubMed ID: 36978134
[TBL] [Abstract][Full Text] [Related]
6. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.
Sinha P; Delucchi KL; Thompson BT; McAuley DF; Matthay MA; Calfee CS;
Intensive Care Med; 2018 Nov; 44(11):1859-1869. PubMed ID: 30291376
[TBL] [Abstract][Full Text] [Related]
7. Effect of Rosuvastatin on Acute Kidney Injury in Sepsis-Associated Acute Respiratory Distress Syndrome.
Hsu RK; Truwit JD; Matthay MA; Levitt JE; Thompson BT; Liu KD
Can J Kidney Health Dis; 2018; 5():2054358118789158. PubMed ID: 30116543
[TBL] [Abstract][Full Text] [Related]
8. Machine Learning Classifier Models Can Identify Acute Respiratory Distress Syndrome Phenotypes Using Readily Available Clinical Data.
Sinha P; Churpek MM; Calfee CS
Am J Respir Crit Care Med; 2020 Oct; 202(7):996-1004. PubMed ID: 32551817
[No Abstract] [Full Text] [Related]
9. Statin therapy as prevention against development of acute respiratory distress syndrome: an observational study.
Bajwa EK; Malhotra CK; Thompson BT; Christiani DC; Gong MN
Crit Care Med; 2012 May; 40(5):1470-7. PubMed ID: 22430234
[TBL] [Abstract][Full Text] [Related]
10. Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome.
Seam N; Meduri GU; Wang H; Nylen ES; Sun J; Schultz MJ; Tropea M; Suffredini AF
Crit Care Med; 2012 Feb; 40(2):495-501. PubMed ID: 21983371
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials.
Santhakumaran S; Gordon A; Prevost AT; O'Kane C; McAuley DF; Shankar-Hari M
Crit Care; 2019 May; 23(1):156. PubMed ID: 31053084
[TBL] [Abstract][Full Text] [Related]
12. Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study.
Mansur A; Steinau M; Popov AF; Ghadimi M; Beissbarth T; Bauer M; Hinz J
BMC Med; 2015 Jun; 13():128. PubMed ID: 26033076
[TBL] [Abstract][Full Text] [Related]
13. HMG-CoA reductase inhibitors (statins) and acute kidney injury: A secondary analysis of renal study outcomes.
Wang AY; Trongtrakul K; Bellomo R; Li Q; Cass A; Gallagher M;
Nephrology (Carlton); 2019 Sep; 24(9):912-918. PubMed ID: 31058387
[TBL] [Abstract][Full Text] [Related]
14. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial.
Fowler AA; Truwit JD; Hite RD; Morris PE; DeWilde C; Priday A; Fisher B; Thacker LR; Natarajan R; Brophy DF; Sculthorpe R; Nanchal R; Syed A; Sturgill J; Martin GS; Sevransky J; Kashiouris M; Hamman S; Egan KF; Hastings A; Spencer W; Tench S; Mehkri O; Bindas J; Duggal A; Graf J; Zellner S; Yanny L; McPolin C; Hollrith T; Kramer D; Ojielo C; Damm T; Cassity E; Wieliczko A; Halquist M
JAMA; 2019 Oct; 322(13):1261-1270. PubMed ID: 31573637
[TBL] [Abstract][Full Text] [Related]
15. [Statin in the treatment of ALI/ARDS: a systematic review and Meta-analysis based on international databases].
Chen M; Lu J; Chen Q; Cheng L; Geng Y; Jiang H; Wang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):51-56. PubMed ID: 28459404
[TBL] [Abstract][Full Text] [Related]
16. Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome.
O'Neal HR; Koyama T; Koehler EA; Siew E; Curtis BR; Fremont RD; May AK; Bernard GR; Ware LB
Crit Care Med; 2011 Jun; 39(6):1343-50. PubMed ID: 21336116
[TBL] [Abstract][Full Text] [Related]
17. Plasma renin as a novel prognostic biomarker of sepsis-associated acute respiratory distress syndrome.
Chakradhar A; Baron RM; Vera MP; Devarajan P; Chawla L; Hou PC
Sci Rep; 2024 Mar; 14(1):6667. PubMed ID: 38509149
[TBL] [Abstract][Full Text] [Related]
18. Systemic Endothelial Activation Is Associated With Early Acute Respiratory Distress Syndrome in Children With Extrapulmonary Sepsis.
Whitney JE; Zhang B; Koterba N; Chen F; Bush J; Graham K; Lacey SF; Melenhorst JJ; Teachey DT; Mensinger JL; Yehya N; Weiss SL
Crit Care Med; 2020 Mar; 48(3):344-352. PubMed ID: 32058372
[TBL] [Abstract][Full Text] [Related]
19. Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration.
Meyer NJ; Reilly JP; Anderson BJ; Palakshappa JA; Jones TK; Dunn TG; Shashaty MGS; Feng R; Christie JD; Opal SM
Crit Care Med; 2018 Jan; 46(1):21-28. PubMed ID: 28991823
[TBL] [Abstract][Full Text] [Related]
20. Plasma Adiponectin, clinical factors, and patient outcomes during the acute respiratory distress syndrome.
Walkey AJ; Demissie S; Shah D; Romero F; Puklin L; Summer RS
PLoS One; 2014; 9(9):e108561. PubMed ID: 25259893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
